# nintedanib

NDC: 68462-802
Generic name: nintedanib
Labeler / Manufacturer: Glenmark Pharmaceuticals Inc., USA
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20260709

FDA application: ANDA212555

## Active ingredients

- NINTEDANIB ESYLATE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68462-802"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68462-802
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b14164fb-0276-4ad1-a5ff-400ab9e292da